| Market Cap | ₹107Cr | 
| ROE | 1.26% | 
| P/E Ratio(TTM) | 250.00 | 
| EPS(TTM) | 0.04 | 
| P/B Ratio | 1.78 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 40.62 | 
| Book Value | 5.62 | 
| Debt to Equity | 0.19 | 
| Face Value | 2 | 
| Parent Organisation | Vaishali Pharma Limited | 
| Managing Director | Mr. Atul Vasani | 
| NSE Symbol | VAISHALI | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%)  | 86.40  | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%)  | 39.18  | ||
| Emcure Pharmaceuticals | NA (0.00%)  | 32.65  | ||
| Wockhardt | NA (0.00%)  | -450.62  |